Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia-Reference-Cited by-同舟云学术

Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia

Published:2023-02 Issue:2 Volume:13 Page:739-753
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Xie Zhifu,Zhang Mei,Song Qian,Cheng Long,Zhang Xinwen,Song Gaolei,Sun Xinyu,Gu Min^ORCID,Zhou Chendong,Zhang Yangming,Zhu Kexin,Yin Jianpeng,Chen Xiaoyan,Li Jingya^ORCID,Nan Fajun

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference56 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the european atherosclerosis society consensus panel;Ference;Eur Heart J,2017

2. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis;Silverman;JAMA,2016

3. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the american college of cardiology/american heart association task force on practice guidelines;Stone;Circulation,2014

4. Epidemiology and management of hyperlipidemia;Karr;Am J Manag Care,2017

5. Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol;Xiao;Diabetes,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease;International Journal of Molecular Sciences;2024-08-02

2. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

3. Pentacyclic triterpenoids as potential ACL inhibitors from the rare medicinal plant Semiliquidambar cathayensis;Fitoterapia;2024-07

4. ATP-Citrate Lyase (ACLY): An Extensive Investigation from Molecular Insight to Therapeutic implications;Natural Resources for Human Health;2024-06-05

5. Simultaneous determination of BGT-002 and its acyl glucuronide metabolite ZM326E-M2 in human plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study;Journal of Pharmaceutical and Biomedical Analysis;2024-06